In best-case scenario with COVID-19, since SARS-CoV-2 uses tACE2 to enter the cell, its levels are reduced and ANG II peaks as an early response to SARS-CoV-2 infection, triggering an inflammatory response to fight the viral infection. Here, AGT is linked to COVID-19.